AR010343A1 - Uso de 17 beta-dihidroequilenina o una sal farmaceuticamente aceptable del ester de 17 beta-dihidroequilenina-3-sulfato para la manufactura de unmedicamento como antioxidante y composicion farmaceutica. - Google Patents
Uso de 17 beta-dihidroequilenina o una sal farmaceuticamente aceptable del ester de 17 beta-dihidroequilenina-3-sulfato para la manufactura de unmedicamento como antioxidante y composicion farmaceutica.Info
- Publication number
- AR010343A1 AR010343A1 ARP970105777A ARP970105777A AR010343A1 AR 010343 A1 AR010343 A1 AR 010343A1 AR P970105777 A ARP970105777 A AR P970105777A AR P970105777 A ARP970105777 A AR P970105777A AR 010343 A1 AR010343 A1 AR 010343A1
- Authority
- AR
- Argentina
- Prior art keywords
- beta
- dihydroekylenine
- pharmaceutically acceptable
- acceptable salt
- manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un uso de 17 beta-dihidroequilenina o una sal faramcéuticamente aceptable del ester de 17 beta-dihidroequilenina-3-sulfato para la manufactura de unmedicamento que comprende una cantidad antioxidante de 17 beta- -dihidroequileninao una sal farmacéuticamente aceptable de éster de 17 beta--dihidroequilenina-3-sulfato util a un mamífero que necesite de dicho tratamiento, y un vehículo farmacéuticamente aceptable; composicionfarmacéutica.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76306596A | 1996-12-10 | 1996-12-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR010343A1 true AR010343A1 (es) | 2000-06-07 |
Family
ID=25066793
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970105777A AR010343A1 (es) | 1996-12-10 | 1997-12-09 | Uso de 17 beta-dihidroequilenina o una sal farmaceuticamente aceptable del ester de 17 beta-dihidroequilenina-3-sulfato para la manufactura de unmedicamento como antioxidante y composicion farmaceutica. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0944390A1 (es) |
JP (1) | JP2001506627A (es) |
KR (1) | KR20000069400A (es) |
CN (1) | CN1239891A (es) |
AR (1) | AR010343A1 (es) |
AU (1) | AU744098C (es) |
BR (1) | BR9713998A (es) |
CA (1) | CA2272074A1 (es) |
HU (1) | HUP0000476A3 (es) |
IL (1) | IL130070A0 (es) |
TW (1) | TW422693B (es) |
WO (1) | WO1998025625A1 (es) |
ZA (1) | ZA9711054B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030013692A1 (en) * | 2001-01-19 | 2003-01-16 | Gullans Steven R. | Methods of treating neurological disorders |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4154820A (en) * | 1976-02-23 | 1979-05-15 | Akzona Incorporated | Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers |
IL107343A (en) * | 1992-11-02 | 2003-10-31 | Wyeth Corp | PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN |
US5545635A (en) * | 1995-05-23 | 1996-08-13 | Eli Lilly And Company | Inhibiting bone loss with equilenin |
AU7013296A (en) * | 1995-08-30 | 1997-03-19 | Eli Lilly And Company | N-butylsulfonate esters of estrogens |
-
1997
- 1997-11-27 TW TW086117837A patent/TW422693B/zh not_active IP Right Cessation
- 1997-12-05 EP EP97949738A patent/EP0944390A1/en not_active Withdrawn
- 1997-12-05 WO PCT/US1997/022153 patent/WO1998025625A1/en not_active Application Discontinuation
- 1997-12-05 JP JP52680398A patent/JP2001506627A/ja not_active Ceased
- 1997-12-05 AU AU78452/98A patent/AU744098C/en not_active Ceased
- 1997-12-05 HU HU0000476A patent/HUP0000476A3/hu unknown
- 1997-12-05 KR KR1019997005152A patent/KR20000069400A/ko not_active Application Discontinuation
- 1997-12-05 CA CA002272074A patent/CA2272074A1/en not_active Abandoned
- 1997-12-05 BR BR9713998-0A patent/BR9713998A/pt not_active IP Right Cessation
- 1997-12-05 CN CN97180447A patent/CN1239891A/zh active Pending
- 1997-12-05 IL IL13007097A patent/IL130070A0/xx unknown
- 1997-12-09 ZA ZA9711054A patent/ZA9711054B/xx unknown
- 1997-12-09 AR ARP970105777A patent/AR010343A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA9711054B (en) | 1999-06-09 |
AU7845298A (en) | 1998-07-03 |
HUP0000476A3 (en) | 2001-01-29 |
KR20000069400A (ko) | 2000-11-25 |
BR9713998A (pt) | 2000-02-29 |
EP0944390A1 (en) | 1999-09-29 |
WO1998025625A1 (en) | 1998-06-18 |
CA2272074A1 (en) | 1998-06-18 |
IL130070A0 (en) | 2000-02-29 |
AU744098C (en) | 2003-07-31 |
CN1239891A (zh) | 1999-12-29 |
AU744098B2 (en) | 2002-02-14 |
JP2001506627A (ja) | 2001-05-22 |
HUP0000476A2 (hu) | 2000-10-28 |
TW422693B (en) | 2001-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9204268A (es) | Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma. | |
ES2159591T3 (es) | Composicion de liberacion controlada. | |
AR004700A1 (es) | 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento | |
GEP20002013B (en) | Therapeutical Means | |
ECSP941104A (es) | Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
ES2178430T3 (es) | Utilizacion de composiciones farmaceuticas gelificables en parodontologia. | |
BG105568A (en) | Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent | |
ES488168A0 (es) | Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada. | |
CL2004001191A1 (es) | Compuestos derivados de esteroides 17 alpha-fluoroalquilados, con actividad antigestagena; composicion farmaceutica; combinacion farmaceutica; y uso del compuesto en la preparacion de un medicamento antiestrogenico, para el tratamiento de dismenorrea | |
CL2008003938A1 (es) | Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden de estres postraumatico (divisional sol. 1799-00). | |
ES2192234T3 (es) | Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos. | |
AR006598A1 (es) | "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación" | |
ATE84032T1 (de) | Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. | |
AR006401A1 (es) | Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos. | |
DK1167354T3 (da) | Racemisk huperzin A | |
IT1170214B (it) | Composizione farmaceutica per la cura delle arteriopatie periferiche | |
AR043071A1 (es) | Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceutica | |
IT1263840B (it) | Formulazioni orali di ubidecarenone in forma di capsule | |
RS49602B (sr) | Farmaceutske mikrosfere valproinske kiseline za oralnu upotrebu | |
MX9205568A (es) | Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida. | |
AR008886A1 (es) | Uso de un inhibidor h+,k+-atpasa en la fabricacion de un medicamento para el tratamiento de polipos nasales, del sindrome de widal, uso de dicho inhibidor y un glucocorticoide para la fabricacion de una formulacion farmaceutica y formulacion farmaceutica para administracion simultanea | |
BG105570A (en) | Pharmaceutical compositions for modified release insulin sensitiser | |
AR021086A1 (es) | Omega-amidas de n-arilsulfonil-aminoacidos, un procedimiento para su preparacion, medicamento, uso de dichos compuestos para la preparacion de un medicamento y procedimiento para la preparacion de un medicamento. | |
AR011437A1 (es) | Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento. | |
AR012638A1 (es) | Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |